Joseph S Zakrzewski Cyteir Therapeutics, Inc. (CYT) insider trading activity

Joseph S Zakrzewski is Director of Cyteir Therapeutics, Inc.. Currently has a direct ownership of 227,439 shares of CYT, which is worth approximately $684,591. The most recent transaction as insider was on Feb 06, 2024, when has been sold 14,150 shares (Common Stock) at a price of $1.69 per share, resulting in proceeds of $23,913. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 227K

0% 3M change

47.1% 12M change

Total Value Held $684,591

Joseph S Zakrzewski Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 06 2024	BUY Exercise of conversion of derivative security	$23,913 $1.69 p/Share	14,150 Added 5.86%	227,439 Common Stock
Dec 07 2022	BUY Open market or private purchase	$27,562 $1.3 p/Share	21,202 Added 12.06%	154,618 Common Stock
May 12 2022	BUY Open market or private purchase	$1,196 $1.61 p/Share	743 Added 0.55%	133,416 Common Stock
May 11 2022	BUY Open market or private purchase	$1,700 $1.7 p/Share	1,000 Added 0.75%	132,673 Common Stock
May 10 2022	BUY Open market or private purchase	$93,377 $1.89 p/Share	49,406 Added 27.28%	131,673 Common Stock
Dec 28 2021	BUY Open market or private purchase	$5,920 $9.85 p/Share	601 Added 0.73%	82,267 Common Stock
Dec 27 2021	BUY Open market or private purchase	$3,014 $10.08 p/Share	299 Added 0.36%	81,666 Common Stock
Dec 23 2021	BUY Open market or private purchase	$1,974 $9.87 p/Share	200 Added 0.25%	81,367 Common Stock
Dec 17 2021	BUY Open market or private purchase	$1,976 $9.88 p/Share	200 Added 0.25%	81,167 Common Stock
Dec 15 2021	BUY Open market or private purchase	$39,960 $10.8 p/Share	3,700 Added 4.37%	80,967 Common Stock

Also insider at

AMRN

AMARIN CORP PLCUK Healthcare

XLRN

ACCELERON PHARMA INC Healthcare

Director

SGMO

SANGAMO THERAPEUTICS, INC Healthcare

Director

ANTX

AN2 Therapeutics, Inc. Healthcare

JSZ